Tourniquet vs. Dual-flow Arthroscopy Sheath in Anterior Cruciate Ligament (ACL) Reconstruction
Launched by CENTRE HOSPITALIER INTERCOMMUNAL DE TOULON LA SEYNE SUR MER · Feb 10, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods used during surgery to repair the anterior cruciate ligament (ACL), which is an important ligament in the knee that helps keep it stable. The trial compares the traditional use of a tourniquet, a device that controls bleeding during surgery, with a new technique using a dual-flow arthroscopy sheath, which may reduce complications after surgery. The goal is to see if using the sheath can lead to a quicker recovery and fewer issues like pain or muscle injury.
To participate in this study, patients need to be at least 18 years old and must be having their first ACL reconstruction surgery. Unfortunately, certain individuals, such as those with multiple knee ligament injuries, pregnant women, or those with bleeding disorders, are not eligible to join. Participants will be divided into two groups: one will have surgery with the tourniquet and the other with the dual-flow sheath. Throughout the study, doctors will closely monitor their recovery to understand which method works better. This research could help improve future care for patients undergoing ACL surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary ACL reconstruction
- • Age 18 years or older
- • Provided informed consent prior to study participation
- • Affiliated to or beneficiary of a social security regimen
- Exclusion Criteria:
- • Multi-ligamentous surgery
- • Revision ACL surgery
- • Presence of a meniscal and/or chondral lesion not allowing immediate weight-bearing postoperatively
- • Bleeding disorder
- • Pregnant, parturient or breastfeeding women
- • Patient under legal guardianship
- • Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the objectives of the study objectives
About Centre Hospitalier Intercommunal De Toulon La Seyne Sur Mer
The Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. Located in the Provence-Alpes-Côte d'Azur region of France, this hospital collaborates with various healthcare professionals and research organizations to conduct innovative clinical trials aimed at improving patient outcomes. With a commitment to excellence in patient care and a multidisciplinary approach to research, the Centre Hospitalier Intercommunal plays a pivotal role in addressing healthcare challenges and contributing to the development of new therapeutic options in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulon, Var, France
Hyères, Var, France
Patients applied
Trial Officials
Cédric SIEDLECKI, MD
Study Director
Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer and Centre Hospitalier de Hyères
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported